A genome-wide association study with 1,126,563 individuals identifies new risk loci for Alzheimer’s disease DP Wightman, IE Jansen, JE Savage, AA Shadrin, S Bahrami, D Holland, ... Nature genetics 53 (9), 1276-1282, 2021 | 494 | 2021 |
Association of plasma clusterin concentration with severity, pathology, and progression in Alzheimer disease M Thambisetty, A Simmons, L Velayudhan, A Hye, J Campbell, Y Zhang, ... Archives of general psychiatry 67 (7), 739-748, 2010 | 484 | 2010 |
Review of brief cognitive tests for patients with suspected dementia L Velayudhan, SH Ryu, M Raczek, M Philpot, J Lindesay, M Critchfield, ... International psychogeriatrics 26 (8), 1247-1262, 2014 | 281 | 2014 |
A multicentre validation study of the diagnostic value of plasma neurofilament light NJ Ashton, S Janelidze, A Al Khleifat, A Leuzy, EL van der Ende, ... Nature communications 12 (1), 3400, 2021 | 269 | 2021 |
Risk of developing dementia in people with diabetes and mild cognitive impairment L Velayudhan, M Poppe, N Archer, P Proitsi, RG Brown, S Lovestone The British Journal of Psychiatry 196 (1), 36-40, 2010 | 188 | 2010 |
Association of blood lipids with Alzheimer's disease: A comprehensive lipidomics analysis P Proitsi, M Kim, L Whiley, A Simmons, M Sattlecker, L Velayudhan, ... Alzheimer's & Dementia 13 (2), 140-151, 2017 | 185 | 2017 |
A feasibility and tolerability study of lithium in Alzheimer's disease A Macdonald, K Briggs, M Poppe, A Higgins, L Velayudhan, S Lovestone International Journal of Geriatric Psychiatry: A journal of the psychiatry …, 2008 | 184 | 2008 |
Entorhinal cortex thickness predicts cognitive decline in Alzheimer's disease L Velayudhan, P Proitsi, E Westman, JS Muehlboeck, P Mecocci, B Vellas, ... Journal of Alzheimer's Disease 33 (3), 755-766, 2013 | 158 | 2013 |
Associations of mutually exclusive categories of physical activity and sedentary time with markers of cardiometabolic health in English adults: a cross-sectional analysis of … K Bakrania, CL Edwardson, DH Bodicoat, DW Esliger, JMR Gill, A Kazi, ... BMC public health 16, 1-10, 2015 | 130 | 2015 |
Plasma transthyretin as a candidate marker for Alzheimer's disease L Velayudhan, R Killick, A Hye, A Kinsey, A Güntert, S Lynham, M Ward, ... Journal of Alzheimer's Disease 28 (2), 369-375, 2012 | 114 | 2012 |
Neuropsychiatric symptoms in mild cognitive impairment: a literature review E Martin, L Velayudhan Dementia and Geriatric Cognitive Disorders 49 (2), 146-155, 2020 | 108 | 2020 |
Smell identification function as a severity and progression marker in Alzheimer's disease L Velayudhan, M Pritchard, JF Powell, P Proitsi, S Lovestone International psychogeriatrics 25 (7), 1157-1166, 2013 | 99 | 2013 |
Genetic predisposition to increased blood cholesterol and triglyceride lipid levels and risk of Alzheimer disease: a Mendelian randomization analysis P Proitsi, MK Lupton, L Velayudhan, S Newhouse, I Fogh, M Tsolaki, ... PLoS medicine 11 (9), e1001713, 2014 | 93 | 2014 |
Neurological soft signs in never‐treated schizophrenia G Venkatasubramanian, V Latha, BN Gangadhar, N Janakiramaiah, ... Acta Psychiatrica Scandinavica 108 (2), 144-146, 2003 | 91 | 2003 |
Association between plasma ceramides and phosphatidylcholines and hippocampal brain volume in late onset Alzheimer’s disease M Kim, A Nevado-Holgado, L Whiley, SG Snowden, H Soininen, ... Journal of Alzheimer's Disease 60 (3), 809-817, 2017 | 78 | 2017 |
Smell identification function and Alzheimer's disease: a selective review L Velayudhan Current opinion in psychiatry 28 (2), 173-179, 2015 | 73 | 2015 |
Metabolic effects of breaking prolonged sitting with standing or light walking in older South Asians and White Europeans: a randomized acute study T Yates, CL Edwardson, C Celis-Morales, SJH Biddle, D Bodicoat, ... The Journals of Gerontology: Series A 75 (1), 139-146, 2020 | 72 | 2020 |
Therapeutic potential of cannabinoids in neurodegenerative disorders: a selective review L Velayudhan, E Van Diepen, M Marudkar, O Hands, S Suribhatla, ... Current pharmaceutical design 20 (13), 2218-2230, 2014 | 70 | 2014 |
Mental health of people living with dementia in care homes during COVID-19 pandemic L Velayudhan, D Aarsland, C Ballard International Psychogeriatrics 32 (10), 1253-1254, 2020 | 64 | 2020 |
Assessment and management of neuropsychiatric symptoms in Parkinson’s disease C Mueller, AP Rajkumar, YM Wan, L Velayudhan, D Ffytche, ... CNS drugs 32 (7), 621-635, 2018 | 64 | 2018 |